GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.1592
-0.0809 (-33.69%)
At close: Dec 19, 2025, 4:00 PM EST
0.1597
+0.0005 (0.31%)
After-hours: Dec 19, 2025, 7:59 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $4.73 million as of December 19, 2025. Its market cap has decreased by -77.73% in one year.
Market Cap
4.73M
Enterprise Value
-279.90K
1-Year Change
-77.73%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $4.73M, an increase of 352.99%. That is a compound annual growth rate of 25.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.73M | -79.71% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |